Nebulized Fentanyl in Healthy Volunteers

Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-68
SponsorUniversity Hospital, Rouen

About this trial

Pain constitutes the predominant motive prompting individuals to seek emergency medical attention, accounting for 80% of admissions to emergency departments. Presently, it is imperative to employ expeditious and efficacious analgesia-sedation methodologies, obviating the necessity for intravenous administration, while ensuring the secure delivery of pharmaceutical agents. The objective of this study is to assess the feasibility and comfort of nebulized intranasal or facial aerosol administration of Fentanyl through the implementation of a pharmacokinetic/pharmacodynamic (PK/PD) study

Eligibility criteria

Qualifiers

Age ≥ 18 years and < 68 years

BMI between 19 and 29 kg/m²

Affiliation to a social security scheme

Adult who has read and understood the information letter and signed the consent form

Disqualifiers

Weight < 50 kg

Taking long-term painkillers or narcotics

Sharp pain

Stable chronic pain (>3 months, with or without long-term treatment)

Trial design

Treatments tested in this trial

  • Fentanyl - Inhalation by facial nebulization
  • Fentanyl - Nebulisation

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators